BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10741140)

  • 1. [Ki-1 lymphoma].
    Nakamura S; Ichimura K; Sasaki K; Suzuki R
    Nihon Rinsho; 2000 Mar; 58(3):650-4. PubMed ID: 10741140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity.
    Shiota M; Mori S
    Leukemia; 1997 Apr; 11 Suppl 3():538-40. PubMed ID: 9209450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of t(2;5)(p23;q35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis.
    Beylot-Barry M; Lamant L; Vergier B; de Muret A; Fraitag S; Delord B; Dubus P; Vaillant L; Delaunay M; MacGrogan G; Beylot C; de Mascarel A; Delsol G; Merlio JP
    Am J Pathol; 1996 Aug; 149(2):483-92. PubMed ID: 8701987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The (2;5)(p23;q35) translocation in cell lines derived from malignant lymphomas: absence of t(2;5) in Hodgkin-analogous cell lines.
    Dirks WG; Zaborski M; Jäger K; Challier C; Shiota M; Quentmeier H; Drexler HG
    Leukemia; 1996 Jan; 10(1):142-9. PubMed ID: 8558920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of genomic t(2;5)(p23;q35) break points in patients with anaplastic large cell lymphoma by sequencing long-range PCR products.
    Luthra R; Pugh WC; Waasdorp M; Morris W; Cabanillas F; Chan PK; Sarris AH
    Hematopathol Mol Hematol; 1998; 11(3-4):173-83. PubMed ID: 9844824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of fluorescent in situ hybridization for detection of the t(2;5)(p23;q35) translocation in anaplastic large-cell lymphoma.
    Johnson PW; Leek J; Swinbank K; Angus B; Roberts P; Markham AF; Selby PJ; MacLennan KA
    Ann Oncol; 1997; 8 Suppl 2():65-9. PubMed ID: 9209644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of a subset of CD30+ anaplastic large cell lymphoma by interphase fluorescence in situ hybridization.
    Shin HJ; Thorson P; Gu J; Katz RL
    Diagn Cytopathol; 2003 Aug; 29(2):61-6. PubMed ID: 12889041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of gene expression profile of TPM3-ALK positive anaplastic large cell lymphoma reveals overlapping and unique patterns with that of NPM-ALK positive anaplastic large cell lymphoma.
    Bohling SD; Jenson SD; Crockett DK; Schumacher JA; Elenitoba-Johnson KS; Lim MS
    Leuk Res; 2008 Mar; 32(3):383-93. PubMed ID: 17720243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum.
    Falini B; Bigerna B; Fizzotti M; Pulford K; Pileri SA; Delsol G; Carbone A; Paulli M; Magrini U; Menestrina F; Giardini R; Pilotti S; Mezzelani A; Ugolini B; Billi M; Pucciarini A; Pacini R; Pelicci PG; Flenghi L
    Am J Pathol; 1998 Sep; 153(3):875-86. PubMed ID: 9736036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinicopathological features of anaplastic large cell lymphomas expressing p80NPM/ALK.
    Shiota M; Mori S
    Leuk Lymphoma; 1996 Sep; 23(1-2):25-32. PubMed ID: 9021682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular variant of the NPM-ALK rearrangement of Ki-1 lymphoma involving a cryptic ALK splice site.
    Ladanyi M; Cavalchire G
    Genes Chromosomes Cancer; 1996 Mar; 15(3):173-7. PubMed ID: 8721682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological and phenotypic features in pediatric large cell lymphoma and their correlation with ALK expression and the t(2;5)(p23;q35) translocation.
    Sherman CG; Zielenska M; Lorenzana AN; Pulford KA; Mason DY; Hutchison RE; Thorner PS
    Pediatr Dev Pathol; 2001; 4(2):129-37. PubMed ID: 11178628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage.
    Rassidakis GZ; Sarris AH; Herling M; Ford RJ; Cabanillas F; McDonnell TJ; Medeiros LJ
    Am J Pathol; 2001 Aug; 159(2):527-35. PubMed ID: 11485911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaplastic large cell lymphoma: a distinct molecular pathologic entity: a reappraisal with special reference to p80(NPM/ALK) expression.
    Nakamura S; Shiota M; Nakagawa A; Yatabe Y; Kojima M; Motoori T; Suzuki R; Kagami Y; Ogura M; Morishima Y; Mizoguchi Y; Okamoto M; Seto M; Koshikawa T; Mori S; Suchi T
    Am J Surg Pathol; 1997 Dec; 21(12):1420-32. PubMed ID: 9414185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD30-positive anaplastic large cell lymphoma in childhood: expression of p80npm/alk and absence of Epstein-Barr virus.
    Nakagawa A; Nakamura S; Ito M; Shiota M; Mori S; Suchi T
    Mod Pathol; 1997 Mar; 10(3):210-5. PubMed ID: 9071728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining.
    Lamant L; Meggetto F; al Saati T; Brugières L; de Paillerets BB; Dastugue N; Bernheim A; Rubie H; Terrier-Lacombe MJ; Robert A; Rigal F; Schlaifer D; Shiuta M; Mori S; Delsol G
    Blood; 1996 Jan; 87(1):284-91. PubMed ID: 8547653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements.
    Pittaluga S; Wlodarska I; Pulford K; Campo E; Morris SW; Van den Berghe H; De Wolf-Peeters C
    Am J Pathol; 1997 Aug; 151(2):343-51. PubMed ID: 9250148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The t(2;5) in human lymphomas.
    Kadin ME; Morris SW
    Leuk Lymphoma; 1998 Apr; 29(3-4):249-56. PubMed ID: 9684923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaplastic large cell lymphoma, ALK-positive.
    Ferreri AJ; Govi S; Pileri SA; Savage KJ
    Crit Rev Oncol Hematol; 2012 Aug; 83(2):293-302. PubMed ID: 22440390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The t(2;5)-associated p80 NPM/ALK fusion protein in nodal and cutaneous CD30+ lymphoproliferative disorders.
    Su LD; Schnitzer B; Ross CW; Vasef M; Mori S; Shiota M; Mason DY; Pulford K; Headington JT; Singleton TP
    J Cutan Pathol; 1997 Nov; 24(10):597-603. PubMed ID: 9449486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.